Jorge B.
- Country
- Spain
- Department
- Department of oncology
Research Overview
- Phase I Study of XL092 Monotherapy and Combination Therapy in Advanced Solid Tumors: ccRCC, nccRCC, HR+ BC, mCRPC, and CRC
- Phase 1a/b Study of BGB-58067, an MTA-Cooperative PRMT5 Inhibitor, in Patients with Advanced Solid Tumors with MTAP Deletion or Loss of MTAP Expression
- Phase 1 Evaluation of NDI-219216 in Advanced Solid Tumors with/without Microsatellite Instability and Deficient Mismatch Repair
Data & Insights
Has run more than one trial at 121 of 231 partner sites.
Specializations
Solid Tumor Oncology
This investigator specializes in treating advanced solid tumors across multiple types, with particular focus on developing novel therapeutic approaches for metastatic disease.
- Breast Cancer
- Head and Neck Squamous Cell Carcinoma
- Gynecologic Cancers
Research includes evaluation of combination therapies and immunotherapy approaches for treatment-resistant tumors.
Lung Cancer Research
Dedicated focus on lung cancer therapeutics, particularly investigating targeted treatments for both:
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer
- RAS-Mutated Lung Cancers
Expertise in evaluating novel drug combinations and precision medicine approaches for lung malignancies.
Sarcoma Treatment
Specialized research in soft tissue and bone sarcomas, focusing on developing innovative treatment strategies.
- Advanced Soft Tissue Sarcomas
- Bone Sarcomas
- Combination Therapy Approaches
Investigation of multimodal treatment approaches including targeted therapies and immunotherapy combinations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.